Compare PRGO & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | VIRT |
|---|---|---|
| Founded | 1887 | 2008 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.8B |
| IPO Year | 1991 | 2015 |
| Metric | PRGO | VIRT |
|---|---|---|
| Price | $13.28 | $33.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $22.00 | ★ $41.43 |
| AVG Volume (30 Days) | ★ 3.6M | 831.3K |
| Earning Date | 11-05-2025 | 01-28-2026 |
| Dividend Yield | ★ 8.68% | 2.85% |
| EPS Growth | N/A | ★ 132.69 |
| EPS | N/A | ★ 4.62 |
| Revenue | ★ $4,281,800,000.00 | $2,694,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | N/A | ★ 41.05 |
| 52 Week Low | $12.17 | $31.89 |
| 52 Week High | $30.93 | $45.77 |
| Indicator | PRGO | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 39.65 |
| Support Level | $12.74 | $32.87 |
| Resistance Level | $13.63 | $34.52 |
| Average True Range (ATR) | 0.46 | 0.89 |
| MACD | 0.25 | -0.19 |
| Stochastic Oscillator | 45.13 | 18.20 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.